Trial · NCT00847171
Adverse events35
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
1 to 20 of 35
Download this page as JSON| Type | Event | Organ system | Group | Affected | At risk | Events |
|---|---|---|---|---|---|---|
| other | Erythema/swelling of vaccine sites | Skin and subcutaneous tissue disorders | Trastuzumab, Cyclophosphamide, and a Breast Tumor Vaccine | 20 | 20 | |
| other | Pain/soreness/tenderness of vaccine sites | Skin and subcutaneous tissue disorders | Trastuzumab, Cyclophosphamide, and a Breast Tumor Vaccine | 20 | 20 | |
| other | Pruritus of vaccine sites | Skin and subcutaneous tissue disorders | Trastuzumab, Cyclophosphamide, and a Breast Tumor Vaccine | 20 | 20 | |
| other | Blister at vaccine site | Skin and subcutaneous tissue disorders | Trastuzumab, Cyclophosphamide, and a Breast Tumor Vaccine | 16 | 20 | |
| other | Dry skin at vaccine site | Skin and subcutaneous tissue disorders | Trastuzumab, Cyclophosphamide, and a Breast Tumor Vaccine | 1 | 20 | |
| other | Ecchymosis at vaccine site | Skin and subcutaneous tissue disorders | Trastuzumab, Cyclophosphamide, and a Breast Tumor Vaccine | 6 | 20 | |
| other | Eczema at vaccine site | Skin and subcutaneous tissue disorders | Trastuzumab, Cyclophosphamide, and a Breast Tumor Vaccine | 1 | 20 | |
| other | Edema at vaccine site | Skin and subcutaneous tissue disorders | Trastuzumab, Cyclophosphamide, and a Breast Tumor Vaccine | 1 | 20 | |
| other | Hives at vaccine site | Skin and subcutaneous tissue disorders | Trastuzumab, Cyclophosphamide, and a Breast Tumor Vaccine | 2 | 20 | |
| other | Hyperpigmentation at vaccine site | Skin and subcutaneous tissue disorders | Trastuzumab, Cyclophosphamide, and a Breast Tumor Vaccine | 1 | 20 | |
| other | Rash at vaccine site | Skin and subcutaneous tissue disorders | Trastuzumab, Cyclophosphamide, and a Breast Tumor Vaccine | 2 | 20 | |
| other | Warmth at vaccine site | Skin and subcutaneous tissue disorders | Trastuzumab, Cyclophosphamide, and a Breast Tumor Vaccine | 14 | 20 | |
| other | Anorexia | Gastrointestinal disorders | Trastuzumab, Cyclophosphamide, and a Breast Tumor Vaccine | 5 | 20 | |
| other | Arthralgia | General disorders | Trastuzumab, Cyclophosphamide, and a Breast Tumor Vaccine | 9 | 20 | |
| other | Blisters | Skin and subcutaneous tissue disorders | Trastuzumab, Cyclophosphamide, and a Breast Tumor Vaccine | 2 | 20 | |
| other | Chills | General disorders | Trastuzumab, Cyclophosphamide, and a Breast Tumor Vaccine | 10 | 20 | |
| other | Constipation | Gastrointestinal disorders | Trastuzumab, Cyclophosphamide, and a Breast Tumor Vaccine | 1 | 20 | |
| other | Cramps | Gastrointestinal disorders | Trastuzumab, Cyclophosphamide, and a Breast Tumor Vaccine | 1 | 20 | |
| other | Dizziness | Nervous system disorders | Trastuzumab, Cyclophosphamide, and a Breast Tumor Vaccine | 2 | 20 | |
| other | Eczema | Skin and subcutaneous tissue disorders | Trastuzumab, Cyclophosphamide, and a Breast Tumor Vaccine | 3 | 20 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT00847171/events